In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accriva Diagnostics

Division of WerfenLife Group SA
www.accriva.com

Latest From Accriva Diagnostics

Device/Diagnostics Quarterly Deal-Making Statistics, Q1 2017

Medtech companies brought in $2.3 billion in financing in Q1 2017, a slight decrease from Q4 2016; device M&A deals totaled $5.8 billion, a sharp decline from the prior quarter, but there were some billion-dollar deals. Q1 diagnostics financings – totaling $1.2 billion (thanks to a $900 million Series B round by cancer diagnostics company Grail) – showed a significant increase over the preceding quarter, as did the Q1 M&As at $700 million versus the previous $87 million.

Medical Device In Vitro Diagnostics

Xagenic Inc.

Xagenic Inc.’s Amplified Redox Assay (AuRA) POC system utilizes chip-based arrays of microelectrodes to test samples for the presence of telltale nucleic acid strands. Because it is chip-based, it should be simple to run multiple tests on a single chip, and no sample extraction or preparation is needed to run the test.

BioPharmaceutical Medical Device

Medtech Execs On The Move, February 2014

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

Execs On The Move, February 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Hematology, Coagulation
  • Medical Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • ITC Nexus Holding Co.
  • International Technidyne Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • WerfenLife Group SA
  • Senior Management
  • Scott Cramer, Pres. & CEO
    Greg Tibbitts, CFO
    Matt Bastardi, SVP, Bus. Dev. & Strategy
    Frank LaDuca, PhD, CSO
  • Contact Info
  • Accriva Diagnostics
    Phone: (858) 404-8203
    6260 Sequence Dr.
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register